Fertility preservation in women with CNS tumors

References

• Ostrom QT, Gittleman H, Fulop J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008-2012. Neuro Oncol. 2015;17(Suppl 4):iv1–iv62.
   PubMed Web of Science ®Google Scholar
• Geue K, Richter D, Schmidt R, et al. The desire for children and fertility issues among young German cancer survivors. J Adolesc Health. 2014;54(5):527–535.
   PubMed Web of Science ®Google Scholar
• Penrose R, Beatty L, Mattiske J, et al. Fertility and cancer–a qualitative study of Australian cancer survivors. Support Care Cancer. 2012;20(6):1259–1265.
   PubMed Web of Science ®Google Scholar
• Linkeviciute A, Boniolo G, Chiavari L, et al. Fertility preservation in cancer patients: the global framework. Cancer Treat Rev. 2014;40(8):1019–1027.
   PubMed Web of Science ®Google Scholar
• Broekmans FJ, Verweij PJ, Eijkemans MJ, et al. Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol. Hum Reprod. 2014;29(8):1688–1697.
   PubMed Web of Science ®Google Scholar
• Anderson RA, Cameron DA. Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer. J Clin Endocrinol Metab. 2011;96(5):1336–1343.
   PubMed Web of Science ®Google Scholar
• Bath LE, Anderson RA, Critchley HO, et al. Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia. Hum Reprod. 2001;16(9):1838–1844.
   PubMed Web of Science ®Google Scholar
• Constine LS, Woolf PD, Cann D, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med. 1993;328(2):87–94.
   PubMed Web of Science ®Google Scholar
• Pai HH, Thornton A, Katznelson L, et al. Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001;49(4):1079–1092.
   PubMed Web of Science ®Google Scholar
• Nygaard R, Clausen N, Siimes MA, et al. Reproduction following treatment for childhood leukemia: a population-based prospective cohort study of fertility and offspring. Med Pediatr Oncol. 1991;19(6):459–466.
   PubMedGoogle Scholar
• Green DM, Kawashima T, Stovall M, et al. Fertility of female survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2009;27(16):2677–2685.
   PubMed Web of Science ®Google Scholar
• Green DM, Nolan VG, Kawashima T, et al. Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the childhood cancer survivor study. Fertil Steril. 2011;95(6):1922–1927, 1927 e1921 .
   PubMed Web of Science ®Google Scholar
• Livesey EA, Brook CG. Gonadal dysfunction after treatment of intracranial tumours. Arch Dis Child. 1988;63(5):495–500.
   PubMed Web of Science ®Google Scholar
• Chemaitilly W, Mertens AC, Mitby P, et al. Acute ovarian failure in the childhood cancer survivor study. J Clin Endocrinol Metab. 2006;91(5):1723–1728.
   PubMed Web of Science ®Google Scholar
• Wallace WH, Thomson AB, Saran F, et al. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62(3):738–744.
   PubMed Web of Science ®Google Scholar
• Larsen EC, Schmiegelow K, Rechnitzer C, et al. Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand. 2004;83(1):96–102.
   PubMed Web of Science ®Google Scholar
• Green DM, Whitton JA, Stovall M, et al. Pregnancy outcome of female survivors of childhood cancer: a report from the childhood cancer survivor study. Am J Obstet Gynecol. 2002;187(4):1070–1080.
   PubMed Web of Science ®Google Scholar
• Signorello LB, Cohen SS, Bosetti C, et al. Female survivors of childhood cancer: preterm birth and low birth weight among their children. J Natl Cancer Inst. 2006;98(20):1453–1461.
   PubMedGoogle Scholar
• Levine J, Canada A, Stern CJ. Fertility preservation in adolescents and young adults with cancer. J Clin Oncol. 2010;28(32):4831–4841.
   PubMed Web of Science ®Google Scholar
• Levine JM, Kelvin JF, Quinn GP, et al. Infertility in reproductive-age female cancer survivors. Cancer. 2015;121(10):1532–1539.
   PubMed Web of Science ®Google Scholar
• Chow EJ, Stratton KL, Leisenring WM, et al. Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the childhood cancer survivor study cohort. Lancet Oncol. 2016;17(5):567–576.
   PubMed Web of Science ®Google Scholar
• Preusser M, Seywald S, Elandt K, et al. Pilot study on sex hormone levels and fertility in women with malignant gliomas. J Neurooncol. 2012;107(2):387–394.
   PubMed Web of Science ®Google Scholar
• Sitbon Sitruk L, Sanson M, Prades M, et al. [Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide]. Gynecol Obstet Fertil. 2010;38(11):660–662.
   PubMed Web of Science ®Google Scholar
• Lambertini M, Boni L, Michelotti A, et al. Ovarian suppression with triptorelin during adjuvant breast cancer chemotherapy and long-term ovarian function, pregnancies, and disease-free survival: a randomized clinical trial. JAMA. 2015;314(24):2632–2640.
   PubMed Web of Science ®Google Scholar
• Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy. N Engl J Med. 2015;372(10):923–932.
   PubMed Web of Science ®Google Scholar
• Demeestere I, Brice P, Peccatori FA, et al. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34(22):2568–2574.
   PubMed Web of Science ®Google Scholar
• Lambertini M, Ceppi M, Poggio F, et al. Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies. Ann Oncol. 2015;26(12):2408–2419.
   PubMed Web of Science ®Google Scholar
• Elgindy E, Sibai H, Abdelghani A, et al. Protecting ovaries during chemotherapy through gonad suppression: a systematic review and meta-analysis. Obstet Gynecol. 2015;126(1):187–195.
   PubMed Web of Science ®Google Scholar
• Lambertini M, Del Mastro L, Pescio MC, et al. Cancer and fertility preservation: international recommendations from an expert meeting. BMC Med. 2016;14:1.
   PubMed Web of Science ®Google Scholar
• Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol. 2008;26(16):2630–2635.
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol. 2005;23(19):4347–4353.
   PubMed Web of Science ®Google Scholar
• Oktay K, Turan V, Bedoschi G, et al. Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer. J Clin Oncol. 2015;33(22):2424–2429.
   PubMed Web of Science ®Google Scholar
• Revelli A, Porcu E, Levi Setti PE, et al. Is letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer? Gynecol Endocrinol. 2013;29(11):993–996.
   PubMed Web of Science ®Google Scholar
• Turan V, Bedoschi G, Moy F, et al. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril. 2013;100(6):1681-5.e1.
   PubMed Web of Science ®Google Scholar
• Domingo J, Guillen V, Ayllon Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril. 2012;97(4):930–934.
   PubMed Web of Science ®Google Scholar
• Friedler S, Koc O, Gidoni Y, et al. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis. Fertil Steril. 2012;97(1):125–133.
   PubMed Web of Science ®Google Scholar
• Martinez M, Rabadan S, Domingo J, et al. Obstetric outcome after oocyte vitrification and warming for fertility preservation in women with cancer. Reprod Biomed Online. 2014;29(6):722–728.
   PubMed Web of Science ®Google Scholar
• Donnez J, Dolmans MM, Pellicer A, et al. Fertility preservation for age-related fertility decline. Lancet. 2015;385(9967):506–507.
   PubMed Web of Science ®Google Scholar
• Blumenthal DT, Parreno MG, Batten J, et al. Management of malignant gliomas during pregnancy: a case series. Cancer. 2008;113(12):3349–3354.
   PubMed Web of Science ®Google Scholar
• Pallud J, Duffau H, Razak RA, et al. Influence of pregnancy in the behavior of diffuse gliomas: clinical cases of a French glioma study group. J Neurol. 2009;256(12):2014–2020.
   PubMed Web of Science ®Google Scholar
• Pallud J, Mandonnet E, Deroulers C, et al. Pregnancy increases the growth rates of World Health Organization grade II gliomas. Ann Neurol. 2010;67(3):398–404.
   PubMed Web of Science ®Google Scholar
• Yust-Katz S, De Groot JF, Liu D, et al. Pregnancy and glial brain tumors. Neuro Oncol. 2014;16(9):1289–1294.
   PubMed Web of Science ®Google Scholar
• Zwinkels H, Dorr J, Kloet F, et al. Pregnancy in women with gliomas: a case-series and review of the literature. J Neurooncol. 2013;115(2):293–301.
   PubMed Web of Science ®Google Scholar
• Ronning PA, Helseth E, Meling TR, et al. The effect of pregnancy on survival in a low-grade glioma cohort. J Neurosurg. 2016;125(2):393–400.
   PubMed Web of Science ®Google Scholar
• Pallud J, Peeters S. Letter to the editor: pregnancy, epilepsy, and glioma survival. J Neurosurg. 2016;125(2):518–519.
   PubMed Web of Science ®Google Scholar